Xenon Pharmaceuticals
XENE
XENE
35 hedge funds and large institutions have $31.1M invested in Xenon Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
15.59% less ownership
Funds ownership: 50.87% → 35.28% (-16%)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.86M | |
| 2 | +$308K | |
| 3 | +$191K | |
| 4 |
DMK
David M. Knott
|
+$102K |
| 5 |
SIM
Spark Investment Management
New York
|
+$62K |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$1.28M | |
| 3 | -$580K | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$343K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$50.4K |